- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medical Insight launches IT upgrade
Other headlinesMRI looks for genetic link to OCD
Medical Insight launches IT upgrade
Medical Insight has released a new version of its thin-client image viewer, called EasyViz 3.0. Enhancements include a 3D rendering engine, an image fusion application designed for cancer diagnostics, dedicated mammography functionality for screening and diagnostics, and a new patient study browser, which makes patient history data accessible to the clinician. offers tools to analyze patient images. The PC-based platform uses advanced adaptive streaming to provide instant access to DICOM-quality images.
MRI looks for genetic link to OCD
In what may be the world’s first study combining genetics and imaging, researchers at Wayne State University will use MRI to visualize brain processes they believe reflect the action of genes associated with obsessive-compulsive disorder (OCD). The researchers hope the $6 million project, funded by the NIH National Institute of Mental Health will lead to the discovery of “risk genes" for OCD. Wayne State University researchers will perform the imaging studies at Children's Hospital of Michigan. The team based at the University of Toronto/The Hospital for Sick Children will conduct the genetic studies. Their focus, glutamate, helps turn serotonin and other chemicals on and off in the brain.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
